Search results for "city."

showing 10 items of 12094 documents

Prospective comparison of CT angiography of the legs with intraarterial digital subtraction angiography.

1996

The aim of this study was to determine the accuracy of CT angiography (CTA) with a single spiral acquisition for the diagnosis of arterial stenoses and occlusion in patients with peripheral vascular occlusive disease.In a prospective study, intraarterial digital subtraction angiography and i.v. CTA from the groin to the lower calves were performed on 50 patients with vascular occlusive disease. Maximum-intensity-projection images in multiple views were produced. The accuracy of CTA with and without analysis of the axial scans was determined with digital subtraction angiography as the standard.The sensitivities of CTA were 100% for the diagnosis of femoral artery occlusion, 100% for the dete…

medicine.medical_specialtyTime FactorsArterial Occlusive DiseasesConstriction PathologicSensitivity and Specificitymedicine.arteryOcclusionmedicineHumansRadiology Nuclear Medicine and imagingProspective StudiesAgedPeripheral Vascular DiseasesLegArterial trunkmedicine.diagnostic_testbusiness.industryVascular diseasemusculoskeletal neural and ocular physiologyAngiographyAngiography Digital SubtractionGeneral MedicineDigital subtraction angiographymedicine.diseasePopliteal arteryStenosismedicine.anatomical_structureEvaluation Studies as TopicAngiographyRadiologyTomography X-Ray Computedbusinesspsychological phenomena and processesArteryAmerican Journal of Roentgenology
researchProduct

Lipoic Acid Improves Nerve Blood Flow, Reduces Oxidative Stress, and Improves Distal Nerve Conduction in Experimental Diabetic Neuropathy

1995

OBJECTIVE To determine whether lipoic acid (LA) will reduce oxidative stress in diabetic peripheral nerves and improve neuropathy. RESEARCH DESIGN AND METHODS We used the model of streptozotocin-induced diabetic neuropathy (SDN) and evaluated the efficacy of LA supplementation in improving nerve blood flow (NBF), electrophysiology, and indexes of oxidative stress in peripheral nerves affected by SDN, at 1 month after onset of diabetes and in age-matched control rats. LA, in doses of 20, 50, and 100 mg/kg, was administered intraperitoneally five times per week after onset of diabetes. RESULTS NBF in SDN was reduced by 50% LA did not affect the NBF of normal nerves but improved that of SDN i…

medicine.medical_specialtyTime FactorsDiabetic neuropathyEndocrinology Diabetes and MetabolismNeural Conductionmedicine.disease_causeNerve conduction velocityDiabetes Mellitus Experimentalchemistry.chemical_compoundDiabetic NeuropathiesGanglia SpinalDiabetes mellitusInternal medicineWeight LossInternal MedicinemedicineAnimalsHumansVitamin EAdvanced and Specialized NursingThioctic AcidVitamin A Deficiencybusiness.industryGlutathionemedicine.diseaseGlutathioneSciatic NerveRatsOxidative StressLipoic acidPeripheral neuropathyEndocrinologychemistryRegional Blood FlowSciatic nervebusinessOxidative stressDiabetes Care
researchProduct

D-dimer testing: advantages and limitations in emergency medicine for managing acute venous thromboembolism

2007

Patients with suspected deep vein thrombosis (DVT) or pulmonary embolism (PE) are frequently admitted to an Emergency Department (ED) for initial evaluation. However, management of patients with suspicion of acute venous thromboembolism (VTE) in this clinical setting can be difficult; in fact symptoms and signs of DVT are non-specific and can be found in a broad spectrum of non-thrombotic disorders. An accurate and timely objective diagnosis is necessary for immediate and correct identification of patients with acute VTE, while avoiding the bleeding risk associated with unnecessary anticoagulant therapy in patients where DVT or PE have been ruled out. The diagnostic approach to patients wit…

medicine.medical_specialtyTime FactorsMEDLINEEnzyme-Linked Immunosorbent AssayEnglish languageDiseaseSensitivity and SpecificityFibrin Fibrinogen Degradation ProductsNephelometry and TurbidimetryD-dimermedicineInternal MedicineHumanscardiovascular diseasesProspective cohort studyLetters to the EditorIntensive care medicinePathologicalVenous ThrombosisPregnancybusiness.industryClinical judgementData synthesisEmergency departmentmedicine.diseasePulmonary embolismD-dimer emergency medicine venous thromboembolismVenous thrombosisAcute DiseaseEmergency medicineEmergency MedicineEmergenciesbusinessVenous thromboembolismAlgorithmsBlood samplingInternal and Emergency Medicine
researchProduct

Hypokalemia shortens relative refractory period of peripheral sensory nerves in man

1977

Absolute and relative refractory periods and the sensory conduction velocity of the median and ulnar nerves were determined in six patients suffering from hypokalemia of various origins. Nerve impulse conduction and the absolute refractory period remained normal, but the relative refractory period was shortened to 1.7 to 2.6 ms at serum K+ levels from 1.6 to 2.9 mval/l. As compared with normal values this decrease was statistically significant.

medicine.medical_specialtyTime FactorsNeurologyRefractory Period ElectrophysiologicalRefractory periodbusiness.industryNeural ConductionHypokalemiaSensory systemNormal valuesNerve conduction velocityHypokalemiaPeripheralNeurologyRefractoryAnesthesiamedicineHumansPeripheral NervesNeurology (clinical)medicine.symptombusinessJournal of Neurology
researchProduct

The effect of Dextransulfate 500 on the pathogenesis of herpes simplex virus infections in weanling mice

1978

Intraperitoneal (i.p.) injection of Dextran Sulfate (D.S.) 500 during a limited period of time influences the course of herpes simplex-virus-infections. D.S.500 was found to reduce the resistance of mice for some herpes simplex-virus strains (Len, L3-2s, Haase) if given between 16 hours before and 2 hours after i.p. infection. The decrease of resistance could be correlated with an increase of the virus content of liver, spleen, brain and spinal cord. Injection of herpes simplex-virus-specific immune serum counteracted the effect of D.S.500 on the course of infections. Conversely, D.S.500 increased the resistance of mice to another group of herpes simplex-viruses (strains D-316, Thea, DD), i…

medicine.medical_specialtyTime FactorsvirusesWeanlingMice Inbred StrainsSpleenBiologymedicine.disease_causeVirusPathogenesisMicePeritoneal cavityMedical microbiologySpecies SpecificityVirologymedicineAnimalsSimplexvirusMacrophagesDextransHerpes SimplexGeneral MedicineSpinal cordVirologyHerpes simplex virusmedicine.anatomical_structureImmunologyAdsorptionArchives of Virology
researchProduct

Localization of the bradykinin B2 receptor in uterus, bladder and Madin-Darby canine kidney cells

1997

Kinins are biologically active peptides that act through specific receptors, B1 and B2. Here we describe the localization of the bradykinin B2 receptor in Madin-Darby canine kidney cells and in the uterus and urinary bladder of rat or human origin. We discuss the suitability of anti-peptide antibodies to assess the tissue distribution of bradykinin B2 receptors.

medicine.medical_specialtyTissue FixationReceptor Bradykinin B2Urinary BladderUterusBradykininKidneyRadioligand Assaychemistry.chemical_compoundDogsAntibody SpecificityInternal medicineTumor Cells CulturedmedicineAnimalsHumansTissue DistributionReceptorPharmacologyKidneyParaffin EmbeddingUrinary bladderbiologyurogenital systemReceptors BradykininUterusImmunohistochemistryRadioligand AssayRatsmedicine.anatomical_structureEndocrinologyMicroscopy Fluorescencechemistrybiology.proteinCancer researchAutoradiographyImmunohistochemistryElectrophoresis Polyacrylamide GelFemaleAntibodyCell DivisionImmunopharmacology
researchProduct

The acute myotoxic effects of bupivacaine and ropivacaine after continuous peripheral nerve blockades.

2003

Bupivacaine causes muscle damage. However, the myotoxic potency of ropivacaine is still unexplored. Therefore, we performed this study to compare the effects of bupivacaine and ropivacaine on skeletal muscle tissue in equipotent concentrations. Femoral nerve catheters were inserted into anesthetized minipigs, and 20 mL of either bupivacaine (5 mg/mL) or ropivacaine (7.5 mg/mL) was injected. Subsequently, bupivacaine (2.5 mg/mL) and ropivacaine (3.75 mg/mL) were continuously infused over 6 h. Control animals were treated with corresponding volumes of normal saline. Finally, muscle samples were dissected at injection sites. After processing and staining, histological patterns of muscle damage…

medicine.medical_specialtyTissue Fixationmedicine.drug_classSwinemedicine.medical_treatmentMyotoxinMuscle Fibers SkeletalFemoral nerveMuscular DiseasesPeripheral nervemedicineIn Situ Nick-End LabelingAnimalsEdemaRopivacainePeripheral NervesAnesthetics LocalMuscle SkeletalBupivacaineLocal anestheticbusiness.industryRopivacaineNerve BlockAmidesBupivacaineSurgeryMicroscopy ElectronAnesthesiology and Pain MedicineAnesthesiaToxicityNerve blockSwine MiniatureFemalebusinessmedicine.drugAnesthesia and analgesia
researchProduct

Evaluation of low-dose metronomic (LDM) cyclophosphamide toxicity in cats with malignant neoplasia

2014

Oral administration of low-dose cyclophosphamide in pets with spontaneously occurring malignant neoplasms has become a common practice in veterinary medicine. The purpose of this retrospective study was to investigate toxicity events in cats with spontaneous malignancies receiving cyclophosphamide as a metronomic therapy for at least 1 month. The number and severity of clinical, haematological and biochemical adverse events were recorded according to the Veterinary Cooperative Oncology Group’s Common Terminology Criteria for Adverse Events v1.1 classification scheme. Twenty-four cats were enrolled in the study with a total number of 27 neoplasms: 13 sarcomas, 12 carcinomas, one melanoma an…

medicine.medical_specialtyToceranibCyclophosphamideCat DiseasesGastroenterologyDisease-Free SurvivalDrug Administration ScheduleMetastasisNeoplasmsInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineAnimalsSmall AnimalsAdverse effectAntineoplastic Agents AlkylatingCyclophosphamideNeoplasm StagingRetrospective StudiesCATSDose-Response Relationship Drugbusiness.industryCommon Terminology Criteria for Adverse Eventsmedicine.diseaseSurgeryThalidomideToxicityCatsbusinessmedicine.drugJournal of Feline Medicine and Surgery
researchProduct

Differentialdiagnose Berylliose/Sarkoidose bei einem Zahntechniker

2008

History and clinical findings Sarcoidosis was diagnosed in a dental technician when he was aged 21 years. Two years later prednisolone treatment was started and continued for 14 years because of nonproductive cough with progressive reduction in vital capacity and CO transfer capacity. Subsequently the risk of exposure to beryllium-containing dust in dental laboratories became known. In his case exposure had started before sarcoidosis had been diagnosed and had continued for 16 years. Changes typical of sarcoidosis (unproductive cough and dyspnoea; bihilar lymphadenopathy and reticulonodular marking in the chest radiogram) were now present, at the age of 40 years. Investigations Vital and di…

medicine.medical_specialtyTransfer capacityBerylliosisbusiness.industryNeopterinpeople.professionGeneral MedicineDental technicianmedicine.diseaseDermatologyrespiratory tract diseaseschemistry.chemical_compoundchemistrymedicinePrednisoloneSarcoidosisDifferential diagnosisUnproductive coughpeoplebusinessmedicine.drugDMW - Deutsche Medizinische Wochenschrift
researchProduct

Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome.

2011

Purpose: This study evaluated the safety and effectiveness of long-term enzyme replacement therapy with idursulfase (recombinant human iduronate-2-sulfatase) in patients with Hunter syndrome. Methods: All 94 patients who completed a 53-week double-blinded study of idursulfase enrolled in this open-labeled extension study and received intravenous idursulfase at a dose of 0.5 mg/kg weekly for 2 years, and clinical outcomes and safety were assessed. Results: No change in percent predicted forced vital capacity was seen, but absolute forced vital capacity demonstrated sustained improvement and was increased 25.1% at the end of the study. Statistically significant increases in 6-minute walking t…

medicine.medical_specialtyVital capacityAdolescentIdursulfaseIduronate SulfatasePulmonary function testingInternal medicineMedicineHumansEnzyme Replacement TherapyMucopolysaccharidosis type IIAdverse effectChildInfusions IntravenousGenetics (clinical)GlycosaminoglycansMucopolysaccharidosis IIbusiness.industryPercent Predicted Forced Vital CapacityHunter syndromeEnzyme replacement therapyOrgan Sizemedicine.diseaseSurgeryTreatment OutcomeLiverChild PreschoolbusinessSpleenmedicine.drugGenetics in medicine : official journal of the American College of Medical Genetics
researchProduct